Blood Reflux Protection 24/7!™
You deserve a partner at both ends of your catheter!
©2016 Nexus Medical
11315 Strang Line Rd Lenexa, KS 66215
Tel: (866) 336-3987• (913) 451-2234• Fax: (913) 451-2363
Products & Solutions
Infusion Therapy
Nexus TKO® (To Keep Open)
Nexus NIS® (Nexus Injection Site)
Support
About Us
Patents
Contact
The History of Nexus Medical, LLC
The Beginning – 2000
Nexus Medical LLC began in 2000 when the Company was awarded a grant from the US Army Medical
Material Command in Fort Detrick Maryland to solve the problems associated with unintentional Blood Reflux
into I.V. catheters and the many unintended consequences it caused for the wounded Army Soldier, Marine
and Military Clinicians.
Research – 2001
Nexus Medical’s Engineers learned Blood Reflux was caused by a multiplicity of external and internal
conditions which occurred during the helicopter airlift evacuation or in the first MASH field hospital.
Study and Develop – 2002
Nexus Medical’s Engineers lab tested and studied the human factors associated with the internal and external pressures which cause “Blood
Reflux” into PIV, Medline, PICC and CVC Catheters. The root causes of Blood Reflux can be characterized in two very clear categories which we
refer to as mechanical and physiological conditions.
Patent – 2002
Nexus Medical filed the first of many Nexus TKO® US and Foreign patent in 2002 for our Dome Shaped Pressure Activated Anti-Reflux Valve
Technology
FDA Approved Nexus TKO®-1 – 2003
510K: K024363
Nexus Medical submitted the first FDA 510K for a Luer-Activated Needle Free Device which had the Pressure Activated Anti-Reflux Valve feature.
We called this new “Anti-Reflux” device the TKO (To Keep Open)
1st Clinical Trial – 2004
Clinical Trial for the Nexus TKO®-1 was conducted at Wilford Hall Medical Center, San Antonio, Texas in the Bone Marrow Transplant Area
Nexus NIS-2 & NIS-7 – 2004
NIS-2 and NIS-7 Luer-Activated Injection Site Devices (Non TKO)
FDA Approved Nexus TKO®-3, Nexus TKO®-4 & Nexus TKO®-4S – 2004
510K: K041845
Nexus TKO®-3, Nexus TKO®-4 & Nexus TKO®-4S Luer Lock Devices
FDA Approved Nexus TKO®-5 – 2005
510K: K053129
Nexus TKO®-5 Split Septum Anti-Reflux Device
Nexus TKO®-5 – 2005
While using the Nexus TKO®-5 on PICC and CVC lines, Wesley Medical Center reduced tPA usage by over 71% while eliminating Heparin on all
flush procedures
FDA Approved Pressure-Rated Extension Sets – 2009/2011
Maximum Pressure = 325 psi
510K: K092382
In 2009 Nexus developed a Standardbore line of pressure-rated extension sets, in 2011 the line was extended with Microbore extension sets
510K Approved Nexus TKO®-6 – 2012
510K: K113398
Nexus TKO®-6 launched in 2012 with the introduction of the markets first crystal clear neutral pressure anti-reflux technology. Nexus has been
committed to a crystal clear fluid pathway from the very first Nexus TKO®-1 in 2003
READ MORE